Lannett Company Inc LCI:NYSE

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 09/30/22 EDT
0.45UNCH (UNCH)
Volume
558
Close
0.45quote price arrow down-0.0129 (-2.7868%)
Volume
52,619
52 week range
0.43 - 3.11
Loading...
  • Open0.4529
  • Day High0.4769
  • Day Low0.45
  • Prev Close0.4629
  • 52 Week High3.11
  • 52 Week High Date09/30/21
  • 52 Week Low0.43
  • 52 Week Low Date09/16/22

Key Stats

  • Market Cap19.33M
  • Shares Out42.96M
  • 10 Day Average Volume0.23M
  • Dividend-
  • Dividend Yield-
  • Beta0.97
  • YTD % Change-72.22

KEY STATS

  • Open0.4529
  • Day High0.4769
  • Day Low0.45
  • Prev Close0.4629
  • 52 Week High3.11
  • 52 Week High Date09/30/21
  • 52 Week Low0.43
  • 52 Week Low Date09/16/22
  • Market Cap19.33M
  • Shares Out42.96M
  • 10 Day Average Volume0.23M
  • Dividend-
  • Dividend Yield-
  • Beta0.97
  • YTD % Change-72.22

RATIOS/PROFITABILITY

  • EPS (TTM)-5.73
  • P/E (TTM)-0.08
  • Fwd P/E (NTM)-0.26
  • EBITDA (TTM)-35.882M
  • ROE (TTM)-18,622.01%
  • Revenue (TTM)340.58M
  • Gross Margin (TTM)9.74%
  • Net Margin (TTM)-68.01%
  • Debt To Equity (MRQ)-244.94%

EVENTS

  • Earnings Date11/01/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Lannett Company Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Lannett Company, Inc. is engaged in the development, manufacturing, marketing and distribution of generic versions of brand pharmaceutical products. The Company markets approximately 100 products, mainly tablet, capsule or liquid oral generic medications. Its marketed products include generics such as Posaconazole, Fluphenazine, Levothyroxine, Sumatriptan and NDA-based product Numbrino. The Company’s product portfolio include Amphetamine IR Tablets, which are used to treat...
Patrick Lepore
Non-Executive Independent Chairman of the Board
Timothy Crew
Chief Executive Officer, Director
John Abt
Vice President and Chief Quality and Operations Officer
John Kozlowski
Chief Financial Officer, Principal Accounting Officer, Vice President - Finance
Samuel Israel J.D.
General Counsel, Chief Legal Officer
Address
1150 Northbrook Drive, Suite 155
Trevose, PA
19053
United States

Top Peers

SYMBOLLASTCHG%CHG
EGRX
Eagle Pharmaceuticals Inc
26.42-2.18-7.62%
ACOR
Acorda Therapeutics Inc
0.299+0.0223+8.06%
THRN
Thorne Healthtech Inc
4.73-0.05-1.05%
COLL
Collegium Pharmaceutical Inc
16.02+0.18+1.14%
ASRT
Assertio Holdings Inc
2.27+0.10+4.61%